THE RELATIVE BIOAVAILABILITY AND PHARMACODYNAMICS OF TWO FORMULATIONS OF TROPIFEXOR, A POTENT FXR AGONIST, IN HEALTHY SUBJECTS.

Chen, J; Gu, J; Choudhury, S; Gadhia, H; Shah, B; Prince, W; Klickstein, L; Woessner, R

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020; 107 (): S79